77 related articles for article (PubMed ID: 8649848)
1. The v-erbA oncogene selectively inhibits iodide uptake in rat thyroid cells.
Trapasso F; Martelli ML; Battaglia C; Angotti E; Mele E; Stella A; Samarut J; Avvedimento VE; Fusco A
Oncogene; 1996 May; 12(9):1879-88. PubMed ID: 8649848
[TBL] [Abstract][Full Text] [Related]
2. p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation.
Casamassimi A; Miano MG; Porcellini A; De Vita G; de Nigris F; Zannini M; Di Lauro R; Russo T; Avvedimento VE; Fusco A
Cancer Res; 1998 Jul; 58(13):2888-94. PubMed ID: 9661907
[TBL] [Abstract][Full Text] [Related]
3. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
[TBL] [Abstract][Full Text] [Related]
4. TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line.
Portella G; Vitagliano D; Li Z; Sferratore F; Santoro M; Vecchio G; Fusco A
Oncol Res; 1998; 10(9):441-7. PubMed ID: 10223619
[TBL] [Abstract][Full Text] [Related]
5. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
[TBL] [Abstract][Full Text] [Related]
6. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
7. Dual effect of transforming growth factor beta on rat thyroid cells: inhibition of thyrotropin-induced proliferation and reduction of thyroid-specific differentiation markers.
Colletta G; Cirafici AM; Di Carlo A
Cancer Res; 1989 Jul; 49(13):3457-62. PubMed ID: 2543498
[TBL] [Abstract][Full Text] [Related]
8. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic and dedifferentiating effect of the K-fgf/hst oncogene on rat thyroid PC clone 3 epithelial cells.
Battaglia C; Berlingieri MT; Martelli ML; Trapasso F; Delli Bovi P; Fusco A
Cell Growth Differ; 1993 Mar; 4(3):185-92. PubMed ID: 7682096
[TBL] [Abstract][Full Text] [Related]
10. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells.
Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A
Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635
[TBL] [Abstract][Full Text] [Related]
11. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
[TBL] [Abstract][Full Text] [Related]
12. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells.
Portella G; Vitagliano D; Borselli C; Melillo RM; Salvatore D; Rothstein JL; Vecchio G; Fusco A; Santoro M
Oncol Res; 1999; 11(9):421-7. PubMed ID: 10821536
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cell transformation requires the expression of the HMGA1 proteins.
Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
[TBL] [Abstract][Full Text] [Related]
14. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
Ghysdael J; Beug H
Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
16. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
[TBL] [Abstract][Full Text] [Related]
17. Pivotal role of the RB family proteins in in vitro thyroid cell transformation.
Iuliano R; Trapasso F; Stella A; Le Pera I; Melillo RM; Bruni P; Baldassarre G; Chiariotti L; Santoro M; Viglietto G; Fusco A
Exp Cell Res; 2000 Nov; 260(2):257-67. PubMed ID: 11035920
[TBL] [Abstract][Full Text] [Related]
18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
19. Activation of the cAMP pathway synergistically increases IL-1-induced IL-6 gene expression in FRTL-5 thyroid cells: involvement of AP-1 transcription factors.
Szabo-Fresnais N; Blondeau JP; Pomérance M
Mol Cell Endocrinol; 2008 Mar; 284(1-2):28-37. PubMed ID: 18280640
[TBL] [Abstract][Full Text] [Related]
20. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A
Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
